Fasting induces hepatic NR4A1, which may bind to the putative NBRE of the fibroblast growth factor-21 (FGF21) promoter and regulate FGF21 expression, which plays pivotal roles in the treatment of metabolic syndromes [37]. This evidence concerns the gene FGF21 and metabolic syndrome.